Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-09 4:54 pm Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Farallon Capital Partners L.P. | 5,055,102 9.99% | 5,055,102 (New Position) | View |
| 2023-02-07 5:10 pm Sale | 13G | BETTER THERAPEUTICS INC BTTX | Farallon Capital Partners L.P. | 813,556 3.4% | -536,444 (-39.74%) | View |
| 2023-02-07 5:09 pm Sale | 13G | CLARIVATE PLC CCC | Farallon Capital Partners L.P. | 15,177,433 2.3% | -20,148,467 (-57.04%) | View |
| 2023-02-07 5:09 pm Purchase | 13G | AMYRIS INC AMRS | Farallon Capital Partners L.P. | 1,000,000 0.3% | 1,000,000 (New Position) | View |
| 2023-02-06 4:20 pm Unchanged | 13G | SEP ACQUISITION CORP SEPA | Farallon Capital Partners L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-02-06 09:06 am Purchase | 13G | ENANTA PHARMACEUTICALS INC ENTA | Farallon Capital Partners L.P. | 1,550,000 7.5% | 1,550,000 (New Position) | View |
| 2023-02-03 5:16 pm Purchase | 13G | SAVARA INC SVRA | Farallon Capital Partners L.P. | 11,532,622 9.99% | 11,532,622 (New Position) | View |
| 2023-02-03 5:15 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Farallon Capital Partners L.P. | 1,417,917 9.99% | 1,417,917 (New Position) | View |
| 2023-02-03 5:15 pm Sale | 13G | ARAMARK ARMK | Farallon Capital Partners L.P. | 10,828,884 4.2% | -5,482,500 (-33.61%) | View |
| 2023-02-01 5:16 pm Sale | 13G | IMAGO BIOSCIENCES INC IMGO | Farallon Capital Partners L.P. | 0 0% | -2,671,313 (Position Closed) | View |
| 2023-02-01 5:12 pm Purchase | 13G | GENERATION BIO CO GBIO | Farallon Capital Partners L.P. | 1,249,382 2.1% | 1,249,382 (New Position) | View |
| 2023-02-01 5:09 pm Unchanged | 13G | BIG SKY GROWTH PARTNERS INC BSKYW | Farallon Capital Partners L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-01-31 5:18 pm Purchase | 13G | DISRUPTIVE ACQUISITION CORP I DISA | Farallon Capital Partners L.P. | 1,400,000 5.1% | 1,400,000 (New Position) | View |
| 2023-01-31 5:14 pm Purchase | 13G | BERENSON ACQUISITION CORP I CL BACA | Farallon Capital Partners L.P. | 2,662,500 9.6% | 2,662,500 (New Position) | View |
| 2023-01-31 5:09 pm Unchanged | 13G | ARYA SCIENCES ACQUISITION CORP ARYD | Farallon Capital Partners L.P. | 800,000 5.2% | 0 (Unchanged) | View |
| 2022-10-07 3:12 pm Purchase | 13D | CHANGE HEALTHCARE INC CHNG | Farallon Capital Partners L.P. | 18,076,272 5.5% | 18,076,272 (New Position) | View |
| 2022-09-06 5:41 pm Purchase | 13G | CLARIVATE PLC CCC | Farallon Capital Partners L.P. | 35,325,900 5.2% | 35,325,900 (New Position) | View |
| 2022-07-14 3:55 pm Purchase | 13G | BEAM THERAPEUTICS INC BEAM | Farallon Capital Partners L.P. | 3,551,771 5.1% | 3,551,771 (New Position) | View |
| 2021-11-09 2:40 pm Purchase | 13G | SDCL EDGE ACQ CORP UNIT 1 SEDAU | Farallon Capital Partners L.P. | 1,732,500 9.9% | 1,732,500 (New Position) | View |
| 2021-11-08 1:11 pm Purchase | 13G | BETTER THERAPEUTICS INC BTTX | Farallon Capital Partners L.P. | 1,350,000 5.7% | 1,350,000 (New Position) | View |